Tumor angiogenesis, apoptosis, and p53 oncogene in stage I lung adenocarcinoma

被引:11
作者
Chiba, Y [1 ]
Taniguchi, T [1 ]
Matsuyama, K [1 ]
Sasaki, M [1 ]
Kato, Y [1 ]
Tanaka, H [1 ]
Muraoka, R [1 ]
Tanigawa, N [1 ]
机构
[1] Fukui Med Univ, Dept Surg 2, Matsuoka, Fukui 9101193, Japan
来源
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 1999年 / 29卷 / 11期
关键词
angiogenesis; p53; apoptosis; lung adenocarcinoma; hematogenous metastasis;
D O I
10.1007/BF02482263
中图分类号
R61 [外科手术学];
学科分类号
摘要
The purpose of this study was to clarify which fao tors are important as predictors not only of patient survival but also of hematogenic metastasis in 15 patients with stage I lung adenocarcinoma who underwent curative operation, The relationship between tumor angiogenesis, apoptosis, and p53 oncogene was also studied. A total of 15 patients were divided into two groups: surviving group (n = 7) and nonsurviving (metastasis) group (n = 8), We studied the medical charts, operative records, pathologic reports, and tumor specimens taken at surgical resection, We measured the apoptotic index using the ApopTag kit and the intratumoral microvessel count using an anti-CD34 monoclonal antibody, In addition, immunohistochemical staining for the expression of p53 was conducted simultaneously, The clinicopathological characteristics, including age, sex, tumor size (pT), and histological differentiation, were not significantly different between the surviving and the nonsurviving group, The microvessel count was significantly higher in nonsurviving group than in the surviving group. The apoptotic index and the expression of p53 was not significantly different between the two groups, An inverse correlation between the apoptotic index and microvessel count, and a positive correlation between the expression of p53 and microvessel count, were observed. Angiogenesis may be an important prognostic factor in patients with stage I lung adenocarcinoma.
引用
收藏
页码:1148 / 1153
页数:6
相关论文
共 20 条
[1]   Seminars in medicine of the Beth Israel Hospital, Boston - Clinical applications of research on angiogenesis [J].
Folkman, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (26) :1757-1763
[2]   Bcl2 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma [J].
Fontanini, G ;
Boldrini, L ;
Vignati, S ;
Chinè, S ;
Basolo, F ;
Silvestri, V ;
Lucchi, M ;
Mussi, A ;
Angeletti, CA ;
Bevilacqua, G .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (05) :718-723
[3]   INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER [J].
IGGO, R ;
GATTER, K ;
BARTEK, J ;
LANE, D ;
HARRIS, AL .
LANCET, 1990, 335 (8691) :675-679
[4]   Vascular endothelial growth factor expression in non-small-cell lung cancer: Prognostic significance in squamous cell carcinoma [J].
Imoto, H ;
Osaki, T ;
Taga, S ;
Ohgami, A ;
Ichiyoshi, Y ;
Yasumoto, K .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 115 (05) :1007-1014
[5]  
Koukourakis MI, 1997, INT J CANCER, V74, P565, DOI 10.1002/(SICI)1097-0215(19971219)74:6<565::AID-IJC1>3.0.CO
[6]  
2-S
[7]  
Lu C, 1997, CANCER RES, V57, P221
[8]   RELATION OF NEOVASCULARIZATION TO METASTASIS OF NON-SMALL-CELL LUNG-CANCER [J].
MACCHIARINI, P ;
FONTANINI, G ;
HARDIN, MJ ;
SQUARTINI, F ;
ANGELETTI, CA .
LANCET, 1992, 340 (8812) :145-146
[9]   Tumor angiogenesis as a prognostic marker in operable non-small cell lung cancer [J].
Matsuyama, K ;
Chiba, Y ;
Sasaki, M ;
Tanaka, H ;
Muraoka, R ;
Tanigawa, N .
ANNALS OF THORACIC SURGERY, 1998, 65 (05) :1405-1409
[10]   MUTATIONS IN THE P53 GENE OCCUR IN DIVERSE HUMAN-TUMOR TYPES [J].
NIGRO, JM ;
BAKER, SJ ;
PREISINGER, AC ;
JESSUP, JM ;
HOSTETTER, R ;
CLEARY, K ;
BIGNER, SH ;
DAVIDSON, N ;
BAYLIN, S ;
DEVILEE, P ;
GLOVER, T ;
COLLINS, FS ;
WESTON, A ;
MODALI, R ;
HARRIS, CC ;
VOGELSTEIN, B .
NATURE, 1989, 342 (6250) :705-708